![Chris Harder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Chris Harder worked as the Vice President-Diagnostics at Spartan Bioscience, Inc. from 2006 to 2018.
He obtained his undergraduate and doctorate degrees from the University of Ottawa.
Precedenti posizioni note di Chris Harder
Società | Posizione | Fine |
---|---|---|
Spartan Bioscience, Inc.
![]() Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | Corporate Officer/Principal | 01/08/2018 |
Formazione di Chris Harder
University of Ottawa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Spartan Bioscience, Inc.
![]() Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | Health Technology |
- Borsa valori
- Insiders
- Chris Harder